Immune and toxic mechanisms in drug-induced agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced / Q000276:immunology*; D000632:Aminopyrine / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000937:Antigen-Antibody Reactions; D013956:Antithyroid Agents / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002701:Chloramphenicol / Q000009:adverse effects; D002746:Chlorpromazine / Q000494:pharmacology / Q000633:toxicity; D004247:DNA / Q000096:biosynthesis; D004342:Drug Hypersensitivity; D004912:Erythrocytes / Q000187:drug effects; D005455:Fluorescent Antibody Technique; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D007970:Leukopenia / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D010640:Phenothiazines / Q000633:toxicity; D011817:Rabbits; D013449:Sulfonamides / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D013956:Antithyroid Agents; D010640:Phenothiazines; D013449:Sulfonamides; D000632:Aminopyrine; D002701:Chloramphenicol; D004247:DNA; D002746:Chlorpromazine